Fresenius SE & Co. KGaA (FRE.DE) Stock

Healthcare · Medical Care Facilities · Member of DAX

Fresenius SE & Co. KGaA (FRE.DE) closed at EUR 43.85 on 2026-10-15, a change of -10.8 % over the past year, with a market capitalization of EUR 25.39B.

Fresenius SE & Co. KGaA recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Fresenius SE & Co. KGaA key figures

Previous close

EUR 43.85 (2026-10-15)

1-year change

-10.8 %

Market cap

EUR 25.39B

Enterprise value

EUR 36.23B

P/E ratio (trailing)

16.16

P/E ratio (forward)

11.40

EPS (trailing)

2.79

EPS (forward)

3.95

PEG ratio

0.78

Price to book

1.29

Revenue growth

5.2 %

Earnings growth

17.2 %

Dividend per share (trailing)

1.05

Short ratio

n/a

Employees

178,486

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Fresenius SE & Co. KGaA and compare it with other stocks.